# Kyle Salyers

> Kyle Salyers is a Series C investor at Health Catalyst backing Medical Device. See 4 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: Angel Investor
- Fund: Health Catalyst
- Location: Indianapolis, United States
- Total investments: 4
- Last investment: Jun 2015
- Lead investor: 25%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/kyle-salyers-b644377/

Kyle Salyers is a Series C investor at Health Catalyst in Indianapolis focused on Medical Device and Medical. Senior Vice President at Health Catalyst.

## Contacts

5 contacts available for Kyle Salyers: work email, personal email, work phone, personal phone and socials. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-email/kyle-salyers?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical Device | 3 | 75% |
| Medical | 2 | 50% |
| Health Care | 2 | 50% |
| Therapeutics | 1 | 25% |
| Biotechnology | 1 | 25% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series C | 2 | 50% |
| Series B | 1 | 25% |
| Series D | 1 | 25% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| NeoChord | NeoChord is a medical device company that has developed a proprietary device that allows mitral valve repair to be performed on a beating heart through a 2 to 3-inch incision between the ribs in patients with severe, degenerative mitral valve regurgitation.In contrast, most mitral valve repair procedures are performed through a 3 to 10-inch chestincision (sternotomy) which involves cutting through the sternum, opening the rib cage, stopping the heart and placing the patient on bypass.Founded in 2007 and is based in St. Louis Park, MN. | $20M | Series C | Jun 09, 2015 |  |
| Mindframe | MindFrame, Inc. develops solutions for treating patients suffering from ischemic stroke. It offers MindFrame Capture LP device that delivers rapid flow restoration and clot extraction to help clinicians provide improved clinical outcomes for their patients. The company also provides MINDFRAME CAPTURE for ICA-T and basilar arteries, and MCAterritory. In addition, it offers MINDFRAME FLOW that creates a bypass for faster flow restoration for transmitting plasminogen activators and plasminogen to thrombus. MindFrame, Inc. was founded in 2007 and is based in Irvine, California. As of July 2, 2012, MindFrame, Inc. operates as a subsidiary of Covidien plc. | $6.5M | Series C | May 18, 2012 |  |
| Mindframe | MindFrame, Inc. develops solutions for treating patients suffering from ischemic stroke. It offers MindFrame Capture LP device that delivers rapid flow restoration and clot extraction to help clinicians provide improved clinical outcomes for their patients. The company also provides MINDFRAME CAPTURE for ICA-T and basilar arteries, and MCAterritory. In addition, it offers MINDFRAME FLOW that creates a bypass for faster flow restoration for transmitting plasminogen activators and plasminogen to thrombus. MindFrame, Inc. was founded in 2007 and is based in Irvine, California. As of July 2, 2012, MindFrame, Inc. operates as a subsidiary of Covidien plc. | $7.1M | Series B | Aug 16, 2010 |  |
| Celleration | Celleration, Inc., a privately held medical device company, was founded in 1999 to develop and commercialize its therapeutic ultrasound platform.Celleration’s core product, the MIST Ultrasound Healing Therapy® System delivers low frequency ultrasound through a saline mist. Unlike conventional wound treatments that are limited to treating thesurface, MIST Therapy delivers ultrasound energy into and below the wound bed to stimulate cells to positively impact all critical aspects of the wound healing process. Celleration received 510K clearance from the FDA in 2005 with the full claim of “promote wound healing”. Shortly thereafter, the company introduced the MIST Therapy System to the US market and has since built an impressive body of clinical evidence demonstrating significant clinical and economic benefits in hundreds of facilities across the United States. Currently, over over 1 million MIST® Therapy treatments have been performed in the United States and U.K. benefiting more than 65,000 patients. | $30M | Series D | Jul 20, 2008 |  |

4 of 4 investments shown.

## Co-investors
- [Ascension Ventures](https://shizune.co/investors/profile/ascension-ventures) — VC Fund, 2 deals together
- [SV Health Investors](https://shizune.co/investors/profile/sv-life-sciences) — VC Fund, 2 deals together
- [Baird Capital](https://shizune.co/investors/profile/baird-capital) — VC Fund, 1 deal together
- [New Science Ventures](https://shizune.co/investors/profile/new-science-ventures) — VC Fund, 1 deal together

## About Health Catalyst

VC Fund · Salt Lake City, United States

Health Catalyst is a tech platform that organizes and links health-related data from different systems. It helps organize, normalize, and link the data from all different systems and make it searchable by all users, even the non-technical.

5 contacts available at Health Catalyst.

| Name | Title | Profile |
| --- | --- | --- |
| Kyle Salyers | Senior Vice President | — |
| Daniel Burton | CEO | — |
| David Burton | Senior Vice President, Future Product Strategy | — |
| Fraser Bullock | Director | https://shizune.co/investors/profile/fraser-bullock |
| Holly Rimmasch | Executive Vice President, Chief Clinical Officer | — |

## Similar investors

### Similar stage
- [Sequoia Capital](https://shizune.co/investors/profile/sequoia-capital) — VC Fund
- [New Enterprise Associates](https://shizune.co/investors/profile/new-enterprise-associates) — VC Fund
- [Bessemer Venture Partners](https://shizune.co/investors/profile/bessemer-venture-partners) — VC Fund

## FAQ

### What does Kyle Salyers invest in?

Kyle Salyers invests primarily in Medical Device, Medical and Health Care startups, most often at Series C and Series B stage. Most of the 4 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Kyle Salyers?

Public channels for Kyle Salyers include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### When did Kyle Salyers last invest?

The most recent investment recorded for Kyle Salyers closed in Jun 2015. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co